By Sydney Halleman | Published June 12, 2026
In a significant shift for the nation’s safety-net health program, the Centers for Medicare & Medicaid Services (CMS) has announced a new regulatory framework that will impose rigorous, front-end fiscal scrutiny on state-led Medicaid demonstrations. Beginning in 2027, states seeking to implement or renew "Section 1115" waivers—the primary vehicle for Medicaid experimentation—will face a more stringent approval process designed to curb what the federal government characterizes as runaway spending and creative budgetary interpretations.
This policy evolution marks the latest chapter in a broader effort by the current administration to reorient the Medicaid program, emphasizing strict financial accountability over the expansive, social-determinant-focused initiatives that characterized the previous administration.
The Role of Section 1115 Waivers
Section 1115 of the Social Security Act grants the Secretary of Health and Human Services the authority to waive certain provisions of federal Medicaid law, allowing states to experiment with innovative service delivery models. These demonstrations are intended to improve health outcomes, streamline care, and test efficiencies that could eventually be scaled nationally.
Nearly every state currently operates under at least one 1115 waiver, with many managing a complex portfolio of demonstrations. These waivers have historically enabled states to tackle specific population needs that fall outside standard Medicaid requirements. For instance, Colorado has leveraged these waivers to provide specialized rehabilitation services for individuals with traumatic brain injuries, while Alabama has utilized them to extend family planning services to women whose pregnancy-related Medicaid coverage would otherwise expire.
However, the scale of these experiments has grown significantly, with demonstrations now accounting for approximately one-third of all federal Medicaid spending. It is this sheer volume of capital that has caught the attention of federal regulators.
A New Chronology of Fiscal Enforcement
The road to the 2027 implementation date is paved with a series of aggressive administrative pivots that began shortly after the start of the current presidential term.
- 2025 – The Reconciliation Package: Following the passage of the "Big Beautiful Bill," the administration secured legislative backing to reform Medicaid funding, mandating stricter fiscal oversight and setting the stage for the first-ever national work requirements for able-bodied Medicaid recipients.
- Early 2026 – Rolling Back Social Determinants: The CMS signaled its departure from previous policies by announcing it would no longer approve or extend waivers aimed at addressing social determinants of health (SDOH)—such as housing stability and nutritional support—arguing that such initiatives stretched the definition of "medical care" beyond its statutory intent.
- Mid-2026 – The Current Guidance: The latest directive establishes the framework for 2027, requiring that the CMS chief actuary perform an independent, pre-approval assessment of "budget neutrality" for every proposed waiver.
- 2027 – The Enforcement Horizon: The new standards become fully effective. By this date, states will also begin navigating the transition to national work requirements, creating a dual-layered challenge for state Medicaid offices.
The "Budget Neutrality" Conflict
At the heart of the new guidance is a battle over the definition of "budget neutrality." By law, 1115 demonstrations must be budget neutral, meaning the federal government should not spend more on the demonstration than it would have spent in the absence of the waiver.
Historically, budget neutrality was evaluated retrospectively. States would operate the program, and at the end of the demonstration period, CMS would determine if the spending fell within the agreed-upon caps. Regulators argue that this "wait and see" approach created a dangerous loophole where runaway spending was identified only after the fact, leaving taxpayers to foot the bill.
"The budget neutrality requirements we plan to propose are designed to ensure that testing new ideas doesn’t cost taxpayers more than current approaches, while improving health outcomes for the people we serve," CMS Administrator Dr. Mehmet Oz said in a statement.
The administration maintains that the previous lack of a statutory definition allowed the "budget neutral" standard to become elastic, essentially acting as a backdoor for states to increase Medicaid funding for programs that may not yield the intended clinical outcomes.
Official Responses and Political Implications
The administration’s stance has been met with both support and alarm. Supporters of the new policy, primarily fiscal conservatives and some governors, argue that the program has become too sprawling and disconnected from its original mission of providing direct medical care. By curbing funding for social services and job training, the administration argues it is protecting the long-term solvency of the Medicaid program for its core beneficiaries.
Conversely, public health advocates and state Medicaid directors have expressed concern. Many argue that the social interventions previously funded through waivers—such as housing support for the chronically ill—are inherently linked to health outcomes. By removing these supports, they contend that the administration may actually increase long-term costs as patients cycle through emergency rooms and inpatient facilities due to preventable, social-related complications.
"We are moving from a model of holistic health to a model of strictly transactional medicine," said one health policy analyst familiar with the negotiations. "While the goal is to stop overspending, the risk is that we are also stopping the very innovations that keep people out of the most expensive parts of the healthcare system."
Implications for States
The immediate impact on states is twofold: fiscal and operational.
1. The Financial Squeeze
States that have relied on federal Medicaid dollars to plug holes in state budgets or to fund expansive social programs will face a stark choice: either terminate those programs or find alternative state funding. With the CMS already deferring or halting millions of dollars in payments to states like California and Minnesota over fraud allegations, the pressure on state treasuries is intensifying.
2. The Operational Burden
The requirement for more rigorous, pre-approval analysis means that state health departments must significantly bolster their actuarial and data-analytics capabilities. States will need to provide granular, data-driven justifications for every dollar requested, a task that many smaller state agencies may find daunting.
CMS has promised to provide technical assistance to states to help them transition to this new era of reporting, but the timeline remains tight. With 2027 approaching, the window to redesign existing waiver applications or to negotiate new terms is rapidly closing.
Conclusion: A Fundamental Reimagining
The 2027 guidance is more than just a procedural change; it represents a fundamental reimagining of the federal-state Medicaid partnership. By asserting the authority of the CMS chief actuary and demanding higher levels of fiscal proof, the federal government is attempting to regain control over a program that has become the largest single item in many state budgets.
As the industry prepares for this transition, the coming months will likely see an uptick in legal challenges and public commentary. Whether this new era of oversight will successfully curb costs without sacrificing the health of the nation’s most vulnerable populations remains the central, unresolved question of this administration’s healthcare agenda. For now, the message from Washington is clear: the era of creative interpretation is over, and the era of strict actuarial compliance has begun.
